November 27, 2017
FDA approves first implanted lens that can be adjusted after cataract surgery
Editor's Note
The Food and Drug Administration (FDA) on November 22 announced the approval of RxSight Inc’s (Pasadena, California) Light Adjustable Lens and Light Delivery Device.
This is the first system that allows ophthalmologists to make small adjustments to the implanted lens’ power after cataract surgery to improve visual acuity without glasses.
Ophthalmologists can make the adjustments during several postoperative in-office procedures.
FDA approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens' power after cataract surgery so that the patient will have better vision when not using glasses.
Free Daily News
- Therapy dogs ease nurse burnout, boost morale
- Personalized perioperative pain management reduces opioid use
- Study: Colibactin-producing gut bacteria fuel colorectal cancer surge
- Augmented reality gains FDA nod, 10k-case milestone in orthopedics, strides in outpatient surgery
- Smart patient selection anchors DISC’s high-acuity spine ASC model
- Postop opioid prescriptions following outpatient surgery see steep, sustained fall
- Study: Bariatric surgery offers cost, survival benefits for cirrhosis patients
- AI monitoring, remote surgery advance
- Rethinking OR routines reduces waste, costs while protecting environment
- Proposed Oregon legislation blocks AI tools from using 'nurse' title
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement